
Tenet Healthcare (THC) Stock Forecast & Price Target
Tenet Healthcare (THC) Analyst Ratings
Bulls say
Tenet Healthcare is well-positioned for growth due to its strategic investments in the higher-margin United Surgical Partners International (USPI) segment, which is expected to enhance the company’s return on invested capital (ROIC) and overall income from equity earnings. The organization is experiencing elevated demand and improved payer mix, coupled with state supplemental payments and reduced labor pressures, creating favorable conditions for margin expansion. Additionally, Tenet's focus on outpatient growth opportunities and a competitive cost structure positions it to benefit from increased visibility into future earnings performance.
Bears say
Tenet Healthcare's stock faces a negative outlook due to significant potential headwinds, including a $220 million impact from subsidy expirations in its Acute segment, which is projected to adversely affect its 2026 forecast. The organization's dependence on non-recurring funds, such as the $148 million from Medicaid in 2025, raises concerns about future revenue stability, further compounded by the expectation that 80-85% of affected individuals may become uninsured. Additionally, a projected 20% decline in Health Insurance Exchange (HIX) coverage could lead to decreased utilization rates, which would likely pressure Tenet's financial performance moving forward.
This aggregate rating is based on analysts' research of Tenet Healthcare and is not a guaranteed prediction by Public.com or investment advice.
Tenet Healthcare (THC) Analyst Forecast & Price Prediction
Start investing in Tenet Healthcare (THC)
Order type
Buy in
Order amount
Est. shares
0 shares